Higuchi John W.
SEC insider (Form 3/4/5 filer). CIK 0001579891. Director at Lipocine Inc. (LPCN). 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in SALT LAKE CITY, UT.
Companies Higuchi John W. has filed insider reports for
- Lipocine Inc. (LPCN): Director
Higuchi John W.
CIK: 0001579891
Transaction Breakdown
Open Market Buys (P)4 (66.7%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LPCN
Lipocine Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 30, 2026LPCN
Lipocine Inc.
PurchaseDirect16K shares at avg. $2.23$36K - Sep 29, 2026LPCN
Lipocine Inc.
PurchaseDirect9K shares at avg. $2.15$19K - Jun 3, 2026LPCN
Lipocine Inc.
AwardDirectCommon Stock (Right to Buy)
1.8K shares at avg. $2.19- - Apr 7, 2026LPCN
Lipocine Inc.
PurchaseDirect40K shares at avg. $2.03$81K - Apr 6, 2026LPCN
Lipocine Inc.
PurchaseDirect123K shares at avg. $2.05$252K - Jun 4, 2025LPCN
Lipocine Inc.
AwardDirectCommon Stock (Right to Buy)
1.8K shares at avg. $3.20-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 | LPCN Lipocine Inc. | Purchase | 15,970 | $2.23 | $35,613 | Direct |
| Sep 29, 2026 | LPCN Lipocine Inc. | Purchase | 9,037 | $2.15 | $19,430 | Direct |
| Jun 3, 2026 | LPCN Lipocine Inc. | Award Common Stock (Right to Buy) | 1,764 | $2.19 | - | Direct |
| Apr 7, 2026 | LPCN Lipocine Inc. | Purchase | 40,000 | $2.03 | $81,200 | Direct |
| Apr 6, 2026 | LPCN Lipocine Inc. | Purchase | 123,000 | $2.05 | $252,150 | Direct |
| Jun 4, 2025 | LPCN Lipocine Inc. | Award Common Stock (Right to Buy) | 1,764 | $3.20 | - | Direct |
1-6 of 6 transactions